7.86k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the most active small-cap stocks by daily trading volume.
Curated by Yahoo Finance
Follow this list to discover and track the most active small-cap stocks by daily trading volume. Although small-cap stocks are generally associated with more risk, they can provide investors large upside potential.
The list includes stocks priced at $5 or more reflecting intraday volume. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called Small Cap Stars.
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.How are these weighted?
The stocks in this watchlist are weighted equally.
|Watchlist||Change today||1-month return||1-year return||Total return|
|Most Active Small-Cap Stocks||+5.44%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|GBTC||Grayscale Bitcoin Trust (BTC)||45.6365||-2.76||-5.71%||3:59 pm GMT-5||12.39M||16.26M||8.02B|
|MAC||The Macerich Company||13.19||-0.60||-4.35%||4:00 pm GMT-5||11.31M||8.31M||2.04B|
|XL||XL Fleet Corp.||14.54||-0.10||-0.68%||4:00 pm GMT-5||8.54M||10.41M||1.91B|
|PING||Ping Identity Holding Corp.||23.34||-9.07||-27.99%||4:00 pm GMT-5||7.63M||1.04M||1.90B|
|BLUE||bluebird bio, Inc.||28.12||+2.20||+8.49%||4:00 pm GMT-5||8.33M||1.74M||1.89B|
|IPOE||Social Capital Hedosophia Holdings Corp. V||18.72||-0.69||-3.55%||4:00 pm GMT-5||7.74M||7.64M||1.88B|
|BCRX||BioCryst Pharmaceuticals, Inc.||10.47||-1.34||-11.35%||4:00 pm GMT-5||7.68M||8.50M||1.85B|
|PBF||PBF Energy Inc.||14.85||-0.48||-3.13%||4:00 pm GMT-5||7.00M||6.57M||1.78B|
|PAND||Pandion Therapeutics, Inc.||59.81||+34.18||+133.36%||4:00 pm GMT-5||8.08M||111.70k||1.77B|
|ERJ||Embraer S.A.||8.94||-0.75||-7.74%||4:00 pm GMT-5||9.69M||3.60M||1.68B|
|GEVO||Gevo, Inc.||10.03||-1.37||-12.02%||4:00 pm GMT-5||16.91M||34.15M||1.54B|
|OCGN||Ocugen, Inc.||8||-0.93||-10.41%||4:00 pm GMT-5||14.75M||85.42M||1.50B|
|CDXC||ChromaDex Corporation||18.74||+9.00||+92.40%||4:00 pm GMT-5||116.70M||523.51k||1.17B|
|LOTZ||CarLotz, Inc.||9.34||-0.43||-4.40%||4:00 pm GMT-5||9.79M||4.10M||1.06B|
|EBON||Ebang International Holdings Inc.||7.46||+0.10||+1.36%||4:00 pm GMT-5||28.82M||12.81M||1.04B|
|RTP||Reinvent Technology Partners||12||-1.46||-10.85%||4:00 pm GMT-5||9.08M||1.46M||1.04B|
|VUZI||Vuzix Corporation||18.08||-0.81||-4.29%||4:00 pm GMT-5||6.52M||4.98M||1.01B|
|CXW||CoreCivic, Inc.||8.23||+0.50||+6.47%||4:00 pm GMT-5||6.36M||2.64M||984.62M|
|GEO||The GEO Group, Inc.||7.77||+0.45||+6.15%||4:00 pm GMT-5||11.41M||4.32M||942.56M|
|VXRT||Vaxart, Inc.||7.5||+0.16||+2.18%||4:00 pm GMT-5||14.45M||15.86M||821.02M|
|SOS||SOS Limited||6.04||-1.54||-20.32%||4:00 pm GMT-5||104.18M||28.03M||749.33M|
|SOLO||Electrameccanica Vehicles Corp.||6.28||-0.40||-5.99%||4:00 pm GMT-5||7.72M||16.59M||618.91M|
|CLVS||Clovis Oncology, Inc.||5.94||-0.26||-4.19%||4:00 pm GMT-5||12.20M||7.78M||614.39M|
|FRX||Forest Road Acquisition Corp.||12.64||-1.40||-9.97%||4:00 pm GMT-5||6.32M||3.13M||474.00M|
|GMBL||Esports Entertainment Group, Inc.||18.52||+0.94||+5.35%||4:00 pm GMT-5||16.07M||1.06M||320.97M|
|KOSS||Koss Corporation||21.53||+3.09||+16.76%||4:00 pm GMT-5||38.33M||2.84M||180.75M|
|WWR||Westwater Resources, Inc.||5.85||-0.59||-9.16%||4:00 pm GMT-5||7.03M||8.87M||172.07M|
|SNSS||Sunesis Pharmaceuticals, Inc.||5.32||+1.04||+24.30%||4:00 pm GMT-5||70.24M||3.17M||96.33M|
|SCKT||Socket Mobile, Inc.||11.74||+1.64||+16.24%||4:00 pm GMT-5||24.45M||4.67M||71.38M|
|SSNT||SilverSun Technologies, Inc.||7.71||+0.46||+6.34%||4:00 pm GMT-5||13.36M||143.78k||34.70M|
Nikola (NKLA) shares rallied after the electric-truck startup announced its fourth quarter results.
Skybridge Capital co-chief investment officer Troy Gayeski shares some quick tips to those investors looking to trade GameStop's stock and other meme stocks.
Merck & Company agreed to snap up Pandion Therapeutics, a clinical-stage biotechnology company, in a deal worth $1.85 billion. Pandion shares jumped almost 133.4% to close at $59.81 on Feb. 25. Per the terms of the deal, the pharmaceutical company will pay $60 per share in cash. Merck (MRK) will acquire all shares of Pandion through a subsidiary, which would initiate a tender offer. The tender offer will close subject to certain conditions. These include the conditions that at least a majority of the total number of Pandion’s fully-diluted common shares are tendered and the expiration of the waiting period is determined as per the Hart-Scott-Rodino Antitrust Improvements Act. Upon completion of the tender offer, the remaining shares of Pandion (PAND) will be canceled and converted into the right to receive at the price tag of $60 per share. The acquisition is likely to close in the first half of 2021. Pandion CEO Dr. Rahul Kakkar said, “Pandion grew out of our founders’ personal and scientific mission to change the way patients living with autoimmune diseases are treated.” “We are proud that Merck has recognized our team’s innovation and drive in creating a pipeline of diverse candidates that activate natural immune regulatory mechanisms and thereby have the potential to achieve better clinical responses for patients,” he added. (See Merck stock analysis on TipRanks) Following the deal, Mizuho Securities analyst Mara Goldstein maintained a Buy rating and a price target of $100. The analyst believes “MRK is augmenting its pipeline (with two clinical, three preclinical, and four discovery programs by YE21) ahead of the expected Organon & Co. Spin off (late 2Q21) with the acquisition of autoimmune-focused company Pandion.” The consensus rating among analysts is a Strong Buy based on 4 Buys versus 1 Hold. The average analyst price target stands at $94.40 and implies upside potential of 26.5% to current levels over the next 12 months. Additionally, Merck scores a 9 out of 10 from TipRanks’ Smart Score rating system, indicating that the stock has strong potential to outperform market expectations. Related News: Western Alliance To Buy AmeriHome For $1B; Shares Drop 3.5% Redfin To Buy RentPath For $608M; Shares Jump 12% Autodesk To Snap Up Innovyze For $1B; Street Sees 14% Upside More recent articles from Smarter Analyst: Beyond Meat Posts Mixed 4Q Results; Street Says Hold Domino’s 4Q Results Miss Analysts’ Expectations; Shares Tank 7% Moderna 4Q Revenues Jump To $571M On Back Of COVID-19 Vaccine; Shares Rise 4% Billionaire Ken Griffin Pulls the Trigger on These 2 Penny Stocks